Intratympanic gentamicin for Ménière's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intratympanic Gentamicin for Ménière's Disease." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/_________Intratympanic_gentamicin_for_Ménière's_disease______. 
Intratympanic gentamicin for Ménière's disease. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/_________Intratympanic_gentamicin_for_Ménière's_disease______. Accessed October 31, 2025.
Intratympanic gentamicin for Ménière's disease. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/_________Intratympanic_gentamicin_for_Ménière's_disease______
Intratympanic Gentamicin for Ménière's Disease [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 October 31]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/_________Intratympanic_gentamicin_for_Ménière's_disease______.
* Article titles in AMA citation format should be in sentence-case
TY  -  ELEC
T1  -           Intratympanic gentamicin for Ménière's disease      
ID  -  451698
BT  -  Evidence-Based Medicine Guidelines
UR  -  https://evidence.unboundmedicine.com/evidence/view/EBMG/451698/all/_________Intratympanic_gentamicin_for_Ménière's_disease______
PB  -  John Wiley & Sons
DB  -  Evidence Central
DP  -  Unbound Medicine
ER  -  

 Evidence-Based Medicine Guidelines
Evidence-Based Medicine Guidelines

